News | Radiation Therapy | August 04, 2016

Elekta’s Monaco 5.11 Treatment Planning System Took Center Stage at AAPM 2016

Latest version of software enables gold standard accuracy combined with speed and performance 

treatment planning

Elekta showcased the latest version of its treatment planning software, Monaco version 5.11 at the 58th American Association of Physicists in Medicine (AAPM) meeting in July. Monaco 5.11, which enables users to attain calculation speeds up to four times faster than previous versions, is cloud capable and is currently installed at several customer sites. Monaco continues to utilize multicriteria optimization and Monte Carlo dose calculations for high-quality dependable treatment planning results.

Monaco templates further increase efficiency by allowing users to easily import and export treatment plans, facilitating best practice sharing across departments and organizations. The ability to create multiple prescription plans simultaneously reduces overall planning time as well. Improved data sharing creates opportunities to optimize individual treatment plans.

“Elekta’s Versa HD linear accelerator and Monaco treatment planning system combine unrivalled dose delivery and intelligent dose planning,” said Elekta’s David Mellenberg, Ph.D., DABR. “The efficiency and precision of Versa HD are enhanced when combined with the Multicriteria Optimization and Gold Standard Monte Carlo calculations in Monaco 5.11. Together, they make dynamic and stereotactic techniques not only possible, but routine practice.”

“We successfully installed Monaco 5.11 at our large center, which treats more than 250 patients daily across two campuses,” said Miller MacPherson, Ph.D., FCCPM, head of physics at The Ottawa Hospital. “VMAT planning is fast and our physics team was able to generate really solid beam models. As a result, we are seeing improvements in IMRT and VMAT QA. We are very pleased with the support we received from Elekta and proud of our physics and planning teams’ accomplishments and hard work transitioning from XiO® to Monaco.”

In addition to Monaco 5.11, the following solutions weree highlighted: The latest version of Mosaiq, which provides numerous workflow enhancements including IQ Scripts Plan of the Day, ePrescribing for controlled substances and many other time saving features; Leksell Gamma Knife Icon, a brain radiosurgery system offering novel technology including true stereotactic CBCT and online adaptive planning capability; iView Dose software, Elekta’s EPID-based in vivo dosimetry solution, which offers an essential safety check during radiation therap ; AQUA, a quality management system which offers a full suite of workflow-oriented machine QA tasks; and Mosaiq Oncology Analytics, which aggregates data to bring clinical, operational and financial insights to the surface.

For more information: www.elekta.com/AAPM

Related Content

Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new
Rising concerns over radiation overexposure teamed with a growing focus on improving the quality of patient care are two key drivers of today’s radiation dose management market. 

Rising concerns over radiation overexposure teamed with a growing focus on improving the quality of patient care are two key drivers of today’s radiation dose management market. 

Feature | Radiation Dose Management | April 02, 2020 | By Melinda Taschetta-Millane
Rising concerns over...
Women are more likely to be cured of cancer by radiotherapy but the side effects are worse.

Women are more likely to be cured of cancer by radiotherapy but the side effects are worse. Image by Mark Kostich

News | Radiation Therapy | March 30, 2020
March 30, 2020 — Women undergoing radiotherapy for
A new framework from an international team of experts aims to help protect patients and providers, and conserve protective equipment for frontline healthcare workers #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Prostate Cancer | March 30, 2020
March 30, 2020 — In the wake of the COVID-19 pan
Accuray Incorporated announced that Mercy Hospital St. Louis continues to demonstrate its commitment to improving patient outcomes with the installation of the first CyberKnife M6 System in Missouri at their state-of-the-art David C. Pratt Cancer Center
News | Stereotactic Body Radiation Therapy (SBRT) | February 27, 2020
February 27, 2020 — Accuray Incorporated announced that Mercy
Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure

Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure. This picture shows a circle of hydrogel that was irradiated on the left half, which is slightly pink; whereas the right half of the gel is not irradiated and remains colorless.

News | Radiation Therapy | February 18, 2020
February 18, 2020 — More than half of all cancer patients undergo radiation therapy and the dose is critical.
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
Accuray TomoTherapy total body irradiation
News | Radiation Therapy | February 07, 2020
February 7, 2020 — Accuray Incorporated announced that two new studies demonstrate the benefits of the ...
The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy

An oxygen map image recovered from a mouse undergoing radiation therapy. The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy (red). Image courtesy of Brian Pogue, PhD

News | Radiation Therapy | February 03, 2020
February 3, 2020 — Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful.